跳到主要内容
  • Sign in
    Welcome !
    My account
    Logout

US BANCORP \DE\ (USB-PQ) Stock Forecast 2025 - AI Price Prediction & Analysis

US BANCORP \DE\ (USB-PQ) AI Stock Price Forecast & Investment Analysis

US BANCORP \DE\ Stock Price Chart and Technical Analysis

Loading US BANCORP \DE\ interactive price chart and technical analysis...

US BANCORP \DE\ (USB-PQ) - Comprehensive Stock Analysis & Investment Research

Deep dive into US BANCORP \DE\'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about US BANCORP \DE\, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For US BANCORP \DE\: US BANCORP \DE\ operates in the Finance sector, positioning it as a large-cap market leader.

US BANCORP \DE\ (Stock Symbol: USB-PQ) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

.

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing US BANCORP \DE\'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For US BANCORP \DE\: With $27835M in annual revenue, the company demonstrates developing profitability.

Annual Revenue: $27835 million .

Market Capitalization: $25209 million - Classified as a large-cap stock with institutional-grade stability.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for US BANCORP \DE\ stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For US BANCORP \DE\: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for US BANCORP \DE\ stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: US BANCORP \DE\'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For US BANCORP \DE\: Market positioning analysis based on available financial and operational metrics.

US BANCORP \DE\ strategically competes in the highly dynamic National Commercial Banks marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

US BANCORP \DE\ (USB-PQ) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for US BANCORP \DE\ stock analysis.

Loading US BANCORP \DE\ comprehensive fundamental analysis and insider trading data...

Deep dive into US BANCORP \DE\'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if US BANCORP \DE\ stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For US BANCORP \DE\: With a P/E ratio of 3.65, the market sees the stock as potentially undervalued.

P/E Ratio 3.65x
P/B Ratio 0.41x
Market Cap $25209M
Dividend Yield 12.47%
EPS $4.18
Book Value/Share $39.12
Revenue/Share $17.71
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently US BANCORP \DE\ converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For US BANCORP \DE\:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess US BANCORP \DE\'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For US BANCORP \DE\:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal US BANCORP \DE\'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For US BANCORP \DE\:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively US BANCORP \DE\ uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For US BANCORP \DE\:

Understanding Financial Statement Data

What these metrics mean: Key figures from US BANCORP \DE\'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For US BANCORP \DE\: With annual revenue of $27835M, US BANCORP \DE\ operates at significant scale.

Income Statement ($ Millions)
Total Revenue $27835M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Dividends Per Share $2.00
Payout Ratio 0.5%
Shares Outstanding 1572M

Latest US BANCORP \DE\ Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting US BANCORP \DE\ (USB-PQ) stock price and investment outlook.

, source: ETF Daily News

US Bancorp DE boosted its holdings in MongoDB, Inc. (NASDAQ:MDB – Free Report) by 8.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission ...

, source: Business Insider

Wells Fargo analyst Mike Mayo maintained a Buy rating on US Bancorp (USB – Research Report) yesterday and set a price target of $56.00. The company’s shares closed yesterday at $43.23. Easily ...

US BANCORP \DE\ Competitors & Peer Analysis - Finance Sector

Comparative analysis of US BANCORP \DE\ against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $580M 15.0x 1.1x
AMJB Unlock Forecast - 30 Days FREE Trial $84691M 1.5x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $894M 243.2x 1.0x
AROW Unlock Forecast - 30 Days FREE Trial $487M 15.9x 1.2x
ASRV Unlock Forecast - 30 Days FREE Trial $47M 12.8x 0.4x
ATLO Unlock Forecast - 30 Days FREE Trial $180M 13.1x 0.9x
BAC Unlock Forecast - 30 Days FREE Trial $381396M 13.6x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $196790M 7.0x 0.7x
BAC-PE Unlock Forecast - 30 Days FREE Trial $165328M 5.9x 0.6x
BAC-PK Unlock Forecast - 30 Days FREE Trial $195170M 7.0x 0.7x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9748114M 347.2x 32.5x
BAC-PM Unlock Forecast - 30 Days FREE Trial $176664M 6.3x 0.6x
BAC-PN Unlock Forecast - 30 Days FREE Trial $163400M 5.8x 0.6x
BAC-PO Unlock Forecast - 30 Days FREE Trial $144045M 5.1x 0.5x
BAC-PP Unlock Forecast - 30 Days FREE Trial $135254M 4.8x 0.5x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $139573M 5.0x 0.5x
BAC-PS Unlock Forecast - 30 Days FREE Trial $155304M 5.5x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1912378M 68.1x 6.4x
BANC Unlock Forecast - 30 Days FREE Trial $2741M 18.6x 0.8x
BANC-PF Unlock Forecast - 30 Days FREE Trial $4101M 27.8x 1.2x
BANF Unlock Forecast - 30 Days FREE Trial $4570M 19.6x 2.7x
BANFP Unlock Forecast - 30 Days FREE Trial $882M 3.8x 0.5x
BCAL Unlock Forecast - 30 Days FREE Trial $530M 30.0x 1.0x
BFC Unlock Forecast - 30 Days FREE Trial $1296M 18.7x 2.1x
BHRB Unlock Forecast - 30 Days FREE Trial $945M 9.0x 1.2x
BML-PG Unlock Forecast - 30 Days FREE Trial $159313M 5.7x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $158388M 5.6x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $164711M 5.9x 0.6x
BML-PL Unlock Forecast - 30 Days FREE Trial $159853M 5.7x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8695M 16.2x 1.5x
C Unlock Forecast - 30 Days FREE Trial $183545M 13.0x 0.9x
CAC Unlock Forecast - 30 Days FREE Trial $687M 14.0x 1.1x
CARE Unlock Forecast - 30 Days FREE Trial $445M 14.2x 1.1x
CASH Unlock Forecast - 30 Days FREE Trial $1848M 10.7x 2.4x
CBNA Unlock Forecast - 30 Days FREE Trial $201M x 1.3x
CBNK Unlock Forecast - 30 Days FREE Trial $575M 13.3x 1.5x
CBU Unlock Forecast - 30 Days FREE Trial $3185M 16.4x 1.7x
CFBK Unlock Forecast - 30 Days FREE Trial $156M 8.6x 0.9x
CFR Unlock Forecast - 30 Days FREE Trial $8343M 13.7x 2.0x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1194M 2.0x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1849M 15.1x 2.4x
CMA Unlock Forecast - 30 Days FREE Trial $9067M 12.5x 1.3x
COF Unlock Forecast - 30 Days FREE Trial $140758M 16.5x 1.3x
COF-PI Unlock Forecast - 30 Days FREE Trial $12982M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $12515M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $12049M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $11383M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $11332M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $58067M 4.1x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1344M 30.5x 0.9x
DCOMG Unlock Forecast - 30 Days FREE Trial $1154M 26.2x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $860M 19.5x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $112M 6.5x 0.8x
EVBN Unlock Forecast - 30 Days FREE Trial $220M 15.2x 1.2x
FBMS Unlock Forecast - 30 Days FREE Trial $199M 15.3x 0.2x
FCF Unlock Forecast - 30 Days FREE Trial $1840M 13.7x 1.2x
FDBC Unlock Forecast - 30 Days FREE Trial $254M 10.7x 1.2x
FFBC Unlock Forecast - 30 Days FREE Trial $2509M 10.5x 1.0x
FHN Unlock Forecast - 30 Days FREE Trial $11942M 14.2x 1.3x
FHN-PB Unlock Forecast - 30 Days FREE Trial $13392M 15.9x 1.5x
FHN-PC Unlock Forecast - 30 Days FREE Trial $13545M 16.1x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $13250M 15.7x 1.5x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9965M 11.8x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2638M x 4.4x
FISI Unlock Forecast - 30 Days FREE Trial $557M 8.1x 0.9x
FLIC Unlock Forecast - 30 Days FREE Trial $269M 14.8x 0.7x
FMCB Unlock Forecast - 30 Days FREE Trial $765M 8.5x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $5980M 12.8x 0.9x
FNLC Unlock Forecast - 30 Days FREE Trial $303M 10.1x 1.1x
FRME Unlock Forecast - 30 Days FREE Trial $2356M 10.4x 1.0x
FRMEP Unlock Forecast - 30 Days FREE Trial $1499M 6.6x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $1079M 12.2x 1.0x
FULT Unlock Forecast - 30 Days FREE Trial $3592M 11.1x 1.1x
FULTP Unlock Forecast - 30 Days FREE Trial $3697M 11.4x 1.1x
FUNC Unlock Forecast - 30 Days FREE Trial $240M 10.1x 1.3x
GNTY Unlock Forecast - 30 Days FREE Trial $569M 15.8x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $753M 11.5x 1.0x
HBAN Unlock Forecast - 30 Days FREE Trial $26320M 12.5x 1.3x
HBANL Unlock Forecast - 30 Days FREE Trial $38360M 18.2x 1.8x
HBANM Unlock Forecast - 30 Days FREE Trial $34099M 16.2x 1.6x
HBANP Unlock Forecast - 30 Days FREE Trial $27864M 13.2x 1.3x
HOPE Unlock Forecast - 30 Days FREE Trial $1415M 33.9x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $219M 10.6x 1.4x
JPM Unlock Forecast - 30 Days FREE Trial $822784M 14.6x 2.3x
JPM-PC Unlock Forecast - 30 Days FREE Trial $71770M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $71068M 1.3x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $59129M 1.1x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $56349M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $57669M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $53034M 0.9x 0.2x
KEY Unlock Forecast - 30 Days FREE Trial $21195M 120.4x 1.1x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27758M 157.7x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $24925M 141.6x 1.3x
KEY-PK Unlock Forecast - 30 Days FREE Trial $25002M 142.1x 1.3x
KEY-PL Unlock Forecast - 30 Days FREE Trial $27504M 156.3x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $158051M 9685.7x 1065.2x
LCNB Unlock Forecast - 30 Days FREE Trial $228M 10.8x 0.9x
MER-PK Unlock Forecast - 30 Days FREE Trial $199874M 7.1x 0.7x
MFG Unlock Forecast - 30 Days FREE Trial $17690M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $179M 9.8x 1.0x
MZHOF Unlock Forecast - 30 Days FREE Trial $82483M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1485M 12.4x 1.1x
NBTB Unlock Forecast - 30 Days FREE Trial $2125M 15.9x 1.2x
NEWT Unlock Forecast - 30 Days FREE Trial $313M 5.9x 1.0x
NEWTG Unlock Forecast - 30 Days FREE Trial $651M 12.2x 2.1x
NEWTH Unlock Forecast - 30 Days FREE Trial $657M 12.3x 2.1x
NEWTI Unlock Forecast - 30 Days FREE Trial $655M 12.3x 2.1x
NEWTZ Unlock Forecast - 30 Days FREE Trial $657M 12.3x 2.1x
NIC Unlock Forecast - 30 Days FREE Trial $2126M 15.7x 1.8x
NKSH Unlock Forecast - 30 Days FREE Trial $198M 17.5x 1.2x
NWBI Unlock Forecast - 30 Days FREE Trial $1604M 11.2x 1.0x
OCFC Unlock Forecast - 30 Days FREE Trial $1062M 12.1x 0.7x
OCFCP Unlock Forecast - 30 Days FREE Trial $1460M 15.2x 0.9x
ONB Unlock Forecast - 30 Days FREE Trial $8961M 15.8x 1.1x
ONBPO Unlock Forecast - 30 Days FREE Trial $9882M 17.4x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9897M 17.4x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $52M 3.6x 0.5x
OPOF Unlock Forecast - 30 Days FREE Trial $215M 24.8x 1.8x
PFIS Unlock Forecast - 30 Days FREE Trial $533M 15.8x 1.1x
PNBK Unlock Forecast - 30 Days FREE Trial $0M -0.7x 0.0x
PNC Unlock Forecast - 30 Days FREE Trial $10M 16.6x 0.0x
PNFP Unlock Forecast - 30 Days FREE Trial $7632M 12.8x 1.2x
PNFPP Unlock Forecast - 30 Days FREE Trial $1934M 3.2x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2755M 16.5x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $24524M 11.8x 1.3x
RF-PC Unlock Forecast - 30 Days FREE Trial $21930M 10.6x 1.2x
RF-PE Unlock Forecast - 30 Days FREE Trial $16874M 8.1x 0.9x
RF-PF Unlock Forecast - 30 Days FREE Trial $23354M 11.2x 1.3x
SASR Unlock Forecast - 30 Days FREE Trial $1263M 19.2x 0.8x
SFNC Unlock Forecast - 30 Days FREE Trial $2619M 16.3x 0.7x
SFST Unlock Forecast - 30 Days FREE Trial $366M 16.8x 1.1x
SHBI Unlock Forecast - 30 Days FREE Trial $566M 10.5x 1.0x
SMBK Unlock Forecast - 30 Days FREE Trial $631M 15.1x 1.2x
SNV Unlock Forecast - 30 Days FREE Trial $7326M 9.3x 1.3x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3606M 4.6x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3818M 4.9x 0.7x
STEL Unlock Forecast - 30 Days FREE Trial $1623M 14.7x 1.0x
TBBK Unlock Forecast - 30 Days FREE Trial $3642M 16.2x 4.2x
TFC Unlock Forecast - 30 Days FREE Trial $58585M -70.3x 4.1x
TRMK Unlock Forecast - 30 Days FREE Trial $2452M 11.3x 1.2x
UBFO Unlock Forecast - 30 Days FREE Trial $167M 14.9x 1.2x
UBOH Unlock Forecast - 30 Days FREE Trial $114M 10.1x 1.4x
UMBF Unlock Forecast - 30 Days FREE Trial $9536M 18.1x 1.3x
UMBFO Unlock Forecast - 30 Days FREE Trial $2017M 3.8x 0.3x
UMBFP Unlock Forecast - 30 Days FREE Trial $1898M x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $76460M 11.1x 1.3x
USB-PA Unlock Forecast - 30 Days FREE Trial $1310739M 189.9x 21.3x
USB-PH Unlock Forecast - 30 Days FREE Trial $31983M 4.6x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $38505M 5.6x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $25209M 3.7x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $26859M 3.9x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $31197M 4.5x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $218M 12.2x 1.3x
VLY Unlock Forecast - 30 Days FREE Trial $6057M 13.4x 0.8x
VLYPN Unlock Forecast - 30 Days FREE Trial $14931M 33.0x 2.0x
VLYPO Unlock Forecast - 30 Days FREE Trial $14221M 31.4x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14480M 32.0x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $74663M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1301M 10.3x 1.4x
WAFD Unlock Forecast - 30 Days FREE Trial $2530M 11.2x 0.8x
WAFDP Unlock Forecast - 30 Days FREE Trial $1400M 6.2x 0.5x
WBHC Unlock Forecast - 30 Days FREE Trial $2103M 33.3x 4.0x
WBS Unlock Forecast - 30 Days FREE Trial $10420M 12.2x 1.1x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3431M 4.0x 0.4x
WBS-PG Unlock Forecast - 30 Days FREE Trial $4129M 4.8x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $263356M 12.8x 1.5x
WFCNP Unlock Forecast - 30 Days FREE Trial $5324M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $65190M 3.2x 0.4x
WFC-PC Unlock Forecast - 30 Days FREE Trial $60731M 3.0x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $60232M 2.9x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $4113064M 199.9x 22.7x
WFC-PY Unlock Forecast - 30 Days FREE Trial $82161M 4.0x 0.5x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $66089M 3.2x 0.4x
WSBC Unlock Forecast - 30 Days FREE Trial $3071M 22.7x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2416M 17.9x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3317M 12.4x 1.2x
ZION Unlock Forecast - 30 Days FREE Trial $8416M 10.0x 1.3x
ZIONL Unlock Forecast - 30 Days FREE Trial $3693M 5.8x 0.6x
ZIONO Unlock Forecast - 30 Days FREE Trial $3699M 5.8x 0.6x
ZIONP Unlock Forecast - 30 Days FREE Trial $3395M 4.0x 0.5x

Frequently Asked Questions - US BANCORP \DE\ Stock Forecast

How accurate are US BANCORP \DE\ stock predictions?

Our AI model demonstrates 10% historical accuracy for USB-PQ predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence US BANCORP \DE\ stock price forecasts?

Our analysis considers US BANCORP \DE\'s financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is US BANCORP \DE\ a good investment in 2025?

Based on our AI analysis, US BANCORP \DE\ shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are US BANCORP \DE\ forecasts updated?

US BANCORP \DE\ stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced US BANCORP \DE\ Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for US BANCORP \DE\ stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...